- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/06 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
Patent holdings for IPC class C07D 211/06
Total number of patents in this class: 304
10-year publication summary
|
18
|
27
|
18
|
29
|
11
|
11
|
12
|
13
|
12
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10262 |
9 |
| Alkermes Pharma Ireland Limited | 254 |
9 |
| The Regents of the University of California | 20745 |
7 |
| Nxera Pharma UK Limited | 189 |
7 |
| The Trustees of Columbia University in the City of New York | 3644 |
6 |
| Abbvie Inc. | 1836 |
5 |
| Amyris, Inc. | 372 |
5 |
| Dongguk University Industry-Academic Cooperation Foundation | 480 |
5 |
| Korea University Research and Business Foundation | 3266 |
5 |
| Alkermes, Inc. | 137 |
4 |
| Meiji Seika Pharma Co., Ltd. | 256 |
4 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3001 |
4 |
| Vernalis (R&D) Limited | 123 |
4 |
| Bristol-myers Squibb Company | 4742 |
3 |
| BASF SE | 21303 |
3 |
| Merck Sharp & Dohme Corp. | 2183 |
3 |
| Bioprojet Pharma | 30 |
3 |
| ChemoCentryx, Inc. | 361 |
3 |
| Les Laboratoires Servier | 496 |
3 |
| The University of Liverpool | 307 |
3 |
| Other owners | 209 |